Trial Profile
Rofecoxib for prevention of procedural pain associated with ureteric stent removal.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Jul 2012
Price :
$35
*
At a glance
- Drugs Rofecoxib (Primary)
- Indications Procedural pain
- Focus Therapeutic Use
- 31 Jul 2012 New trial record